Today is International Clinical Trials Day, a time to recognize the importance of clinical research. At Cytokinetics, we are committed to rigorous research. Since our beginning, we have conducted more than 100 clinical trials in partnership with hundreds of research institutions across the world, and we are grateful to the tens of thousands of participants who have contributed to our clinical trials. Clinical trials are essential to our mission of delivering potential new therapies for patients with cardiovascular diseases of impaired muscle function. #InternationalClinicalTrialDay #Clinicaltrialsday #CTD2025
Cytokinetics
Biotechnology Research
South San Francisco, California 34,981 followers
Empowering Muscle Empowering Lives
About us
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Proud to be a San Francisco Business Times Best Place to Work in 2021 and 2022, a Great Place to Work-Certified company in 2022 and a part of Fortune's Best Workplaces in the Bay Area in 2022 and Fortune's Best Workplaces in BioPharma in 2022.
- Website
-
http://www.cytokinetics.com
External link for Cytokinetics
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- South San Francisco, California
- Type
- Public Company
- Founded
- 1998
- Specialties
- Heart Failure, Amyotrophic Lateral Sclerosis, and Hypertrophic Cardiomyopathy
Locations
-
Primary
Get directions
350 Oyster Point Blvd
South San Francisco, California 94080, US
Employees at Cytokinetics
Updates
-
We’re at the European Society of Cardiology's #HeartFailure2025 in Belgrade, Serbia. Come visit us at booth A10. #HCM #HFA_ESC #heartfailure
-
-
We are pioneers in the field of muscle biology, and for over 25 years we have been driven by passion to make a difference for patients. When you join Cytokinetics, you join a team that is dedicated to excellence, committed to scientific thinking, and grounded in integrity. We encourage independent thought and empowerment, all in service of improving the lives of patients. To learn more about opportunities to join our team, visit our careers page. https://bit.ly/3P5NX4d #EmpoweredAtCytokinetics #TeamCyto #hiring
-
-
Cytokinetics will be presenting at the European Society of Cardiology #HeartFailure2025 Congress. To learn more about the Congress: https://bit.ly/4dcfgnu
-
-
Living with a chronic condition like hypertrophic cardiomyopathy (HCM) isn’t just a physical journey, it’s an emotional one too. The symptoms, the lifestyle changes, and loneliness can take a real toll on mental health. During #MentalHealthAwarenessMonth, we're recognizing the whole-person impact of #HCM and reminding those living with HCM that they are not alone.
-
-
It’s Heart Failure Awareness Days in Europe! As we look ahead to ESC #HeartFailure2025, we're proud to raise awareness around #heartfailure and help inspire change. Learn more about heart failure: https://bit.ly/3RCQ7Zv #HeartFailureAwareness
-
-
We're excited to be attending the European Society of Cardiology's #HeartFailure2025 taking place in Belgrade, Serbia, May 17-20. The Heart Failure Congress brings together experts from around the world to discuss the prevention, diagnosis and treatment of heart failure. https://bit.ly/4iGszxI #HCM #heartfailure
-
-
May is Asian American, Native Hawaiian, and Pacific Islander Heritage Month! Let's celebrate the rich history and contributions of this community—today and every day. #AANHPI #AAPI #AANHPIHeritageMonth
-
Today our President and CEO Robert Blum spoke at the 9th Annual Stanford Drug Discovery Symposium hosted by the Stanford Cardiovascular Institute. This event hosts the drug discovery community, from Nobel Laureates to investors to discuss scientific ideas and innovations. In his presentation, “From Start up to Scale up: A Journey of Innovation, Perseverance, and Fortitude,” Robert highlighted the scientific innovation driving Cytokinetics, the pivotal role of business development in fueling progress, and the unwavering perseverance required to advance the science of muscle biology while building a successful company. #SDDS2025
-
-
We're heading to ISPOR 2025! Join our HEOR team in Montreal May 13 – 16. ISPOR 2025 underscores the importance of health economics and outcomes research in transforming healthcare systems. https://bit.ly/42WFCpd #ISPORAnnual
-